EUVIMEDEUVIMED entdecken
Crossref

Discovery of Thiochroman Derivatives as Potent, Oral Selective Estrogen Receptor Degraders and Antagonists for the Treatment of Endocrine-Resistant Breast Cancer

Dan Zhang iD, Zhengyu Lu, Yongqi He, Xin-Yu Leng iD, Xin Meng, Xiang Lei, Deyu Kong, Lulu Sun, Wenhao Hu iD, Yushe Yang iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c02453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Dan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Selective Estrogen Receptor Modulators. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Youth Innovation Promotion Association of the Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug Resistance, NeoplasmSelective Estrogen Receptor ModulatorsAnimalsFemaleHumansMiceAdministration, OralAntineoplastic AgentsCell Line, TumorDrug DiscoveryEstrogen Receptor alphaEstrogen Receptor AntagonistsMCF-7 CellsMice, NudeStructure-Activity RelationshipXenograft Model Antitumor AssaysIndazoles

Substanzen

Antineoplastic AgentsEstrogen Receptor alphaEstrogen Receptor AntagonistsSelective Estrogen Receptor ModulatorsIndazoles

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China.
  • Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.

ORCID-Profile: Dan Zhang, Xin-Yu Leng, Wenhao Hu, Yushe Yang

Förderung

  • Youth Innovation Promotion Association of the Chinese Academy of Sciences

Zitieren

APA

Zhang, D., Lu, Z., He, Y., Leng, X. Y., Meng, X., Lei, X., Kong, D., Sun, L., Hu, W., & Yang, Y. (2024). Discovery of Thiochroman Derivatives as Potent, Oral Selective Estrogen Receptor Degraders and Antagonists for the Treatment of Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02453

Vancouver

Zhang D, Lu Z, He Y, Leng XY, Meng X, Lei X, et al. Discovery of Thiochroman Derivatives as Potent, Oral Selective Estrogen Receptor Degraders and Antagonists for the Treatment of Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c02453

BibTeX
@article{Zhang2024,
  author = {Zhang, Dan and Lu, Zhengyu and He, Yongqi and Leng, Xin-Yu and Meng, Xin and Lei, Xiang and Kong, Deyu and Sun, Lulu and Hu, Wenhao and Yang, Yushe},
  title = {Discovery of Thiochroman Derivatives as Potent, Oral Selective Estrogen Receptor Degraders and Antagonists for the Treatment of Endocrine-Resistant Breast Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c02453}
}
Kostenlos starten →